Cell cycle regulators in bladder cancer: Relationship to schistosomiasis

IUBMB Life

Volumn 56, Issue 9, 2004, Pages 557-564

  Eissa, Sanaa ^a   Ahmed, Maha Imam ^a   Said, Heba ^a   Zaghlool, Ashraf ^b   El Ahmady, Omar ^c  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b NATIONAL CANCER INSTITUTE   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Bilharziasis; Bladder cancer; Cyclin D; P15; P16; p21; Tumor suppressor genes

Indexed keywords

CYCLIN D1; PROTEIN P15; PROTEIN P16; PROTEIN P21;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SCHISTOSOMIASIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENE DELETION; HUMANS; MALE; MIDDLE AGED; PLACENTA; PREGNANCY; SCHISTOSOMIASIS; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 10344240947     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/15216540400013903     Document Type: Article

References (29)

1. Rosin, M. P., Saad el Din Zaki, S., Ward, A. J., and Anwar, W. A. (1994) Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. Mutat. Res. 305(2), 283-292. Review.
2. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev. 12(15), 2245-2262. Review.
3. Somasondaram, K., and El-Dairy, W. S. (2000) Tumor suppressor p53: regulation and function. Front. Biosci. 5, D424-437.
4. Tut, V. M., Braithwaite, K. L., Angus, B., Neal, D. E., Lunec, J., and Mellon, J. K. (2001) Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Br. J. Cancer 84(2), 270-275.
5. Keshava, C., Frye, B. L., Wolff, M. S., McCanlies, E. C., and Weston, A. (2002) Waf-1 (p21) and p53 polymorphisms in breast cancer. Cancer Epidemiol. Biomarkers Prev. 11(1), 127-130.
6. Hannon, G. J., and Beach, D. (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371(6494), 257-261.
7. Ezoe, S., Matsumura, I., Satoh, Y., Tanaka, H., and Kanakura, Y. (2004) Cell cycle regulation in hematopoietic stem/progenitor cells. Cell Cycle 3(3), 314-318.
8. American Joint Committee on Cancer. (1992) In Manual for Staging of Cancer, 4th edn, (Beahrs, O. H., Henson, D. E., Fluter, R. V. et al., eds). Lippincott, Philadelphia.
9. Eissa, S., and Seada, L. S. (1998) Quantitation of bcl-2 protein in bladder cancer tissue by enzyme immunoassay: comparison with Western blot and immunohistochemistry. Clin. Chem. 44(7), 1423-1429.
10. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning. A Laboratory Manual, 2nd edn. pp. 42-59, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
11. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
12. Jackson, D. P., Hayde, J. D., and Quirke, P. (1991) Extraction of nucleic acids from fresh and archival material. In PCR: A Practical Approach. (McPherson, M. J., Quirke, P. and Taylor, G. R., eds.). pp. 29-49, Oxford University Press.
13. Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S., Willson, J. K., Kinzler, K. W., and Vogelstein, B. (1994) Deletion of p16 and p15 genes in brain tumors. Cancer Res. 54(24), 6353-6358.
14. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson, D. A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368(6473), 753-756.
15. El-Mawla, N. G., el-Bolkainy, M. N., and Khaled, H. M. (2001) Bladder cancer in Africa: update. Semin. Oncol. 28(2), 174-178. Review.
16. Preston-Martin, S., Pike, M. C., Ross, R. K., Jones, P. A., and Henderson, B. E. (1990) Increased cell division as a cause of human cancer. Cancer Res. 50(23), 7415-7421.
17. Lu, X., Toki, T., Konishi, I., Nikaido, T., and Fujii, S. (1998) Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis. Cancer 82(12), 2409-2417.
18. Ames, B. N., and Gold, L. S. (1990) Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 249(4972), 970-997.
19. Eissa, S., Swelam, M., Shaker, Y., Abdel-Fattah, M., and Khalifa, A. (1999) Expression of p21WAF1/CIP1 in bladder cancer: relation to schistosomiasis. IUBMB Life 48(1), 115-119.
20. Korkolopoulou, P., Konstantinidou, A. E., Thomas-Tsagli, E., Christodoulou, P., Kapralos, P., and Davaris, P. (2000) WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer. Appl. Immunohistochem. Mol. Morphol. 8(4), 285-292.
21. Shariat, S. F., Tokunaga, H., Zhou, J., Kim, J., Ayala, G. E., Benedict, W. F., and Lerner, S. P. (2004) p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J. Clin. Oncol. 22(6), 1014-1024.
22. Le Frere-Belda, M. A., Cappellen, D., Daher, A., Gil-Diez-de-Medina, S., Besse, F., Abbou, C. C., Thiery, J. P., Zafrani, E. S., Chopin, D. K., and Radvanyi, F. (2001) p15(INK4b) in bladder carcinomas: decreased expression in superficial tumours. Br. J. Cancer 85(10), 1515-1521.
23. Eissa, S., Ali-Labib, R., and Khalifa, A. (2000) Deletion of p16 and p15 genes In schistosomiasis-associated bladder cancer (SABC). Clin. Chim. Acta 300(1-2), 159-169.
24. Chang, L. L., Yeh, W. T., Yang, S. Y., Wu, W. J., and Huang, C. H. (2003) Genetic alterations of p16INK4a and p14ARF genes in human bladder cancer. J. Urol. 170(2 Pt 1), 595-600.
25. Wu, W. J., Kakehi, Y., Chang, S. F., Huang, C. H., and Chang, L. L. (2000) Genetic alterations of the p16 gene in urothelial carcinoma in Taiwanese patients. BJU Int. 85(1), 143-149.
26. Primdahl, H., von der Maase, H., Sorensen, F. B., Wolf, H., and Orntoft, T. F. (2002) Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer. J. Cancer Res. Clin. Oncol. 128(6), 295-301.
27. Shin, K. Y., Kong, G., Kim, W. S., Lee, T. Y., Woo, Y. N., and Lee, J. D. (1997) Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers. Br. J. Cancer 75(12), 1788-1792.
28. Lee, C. C., Yamamoto, S., Morimura, K., Wanibuchi, H., Nishisaka, N., Ikemoto, S., Nakatani, T., Wada, S., Kishimoto, T., and Fukushima, S. (1997) Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer 79(4), 780-789.
29. Osman, I., Scher, H., Zhang, Z. F., Soos, T. J., Hamza, R., Eissa, S., Khaled, H., Koff, A., and Cordon-Cardo, C. (1997) Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer. Clin. Cancer Res. 3(12 Pt 1): 2247-2251.